交易 Lineage Cell Therapeutics, Inc. - LCTX CFD
新增到我的最愛- 摘要
- 曆史數據
- 活動
- 盈虧控制
- 資産負債表
- 現金流
交易條件
價差 | 0.05 | ||||||||
多頭倉位隔夜費用
多頭隔夜費用
前往平台 | -0.026179% | ||||||||
空頭倉位隔夜費用
空頭隔夜費用
前往平台 | 0.003957% | ||||||||
隔夜費時間 | 21:00 (UTC) | ||||||||
最小成交量 | 1 | ||||||||
貨幣 | USD | ||||||||
保證金 | 5% | ||||||||
股票交易 | United States of America | ||||||||
交易委員會 | 0% |
*Information provided by Capital.com
Lineage Cell Therapeutics Inc ESG Risk Ratings
High Medium Low Negligible
“C”分數表示在公開報告重大 ESG 數據方面令人滿意的相對 ESG 表現和適度的透明度。
- 上週
- 上個月
- 去年
- 過去兩年
- 最大
- 每日
- 每週
- 每月
日期 | 拋售 | 自訂 | 變化 (%) | 打開 | 最高 | 最小 |
---|---|---|---|---|---|---|
Apr 18, 2024 | 1.17 | -0.07 | -5.65% | 1.24 | 1.26 | 1.16 |
Apr 17, 2024 | 1.25 | 0.11 | 9.65% | 1.14 | 1.29 | 1.13 |
Apr 16, 2024 | 1.13 | -0.09 | -7.38% | 1.22 | 1.22 | 1.12 |
Apr 15, 2024 | 1.23 | -0.03 | -2.38% | 1.26 | 1.28 | 1.20 |
Apr 12, 2024 | 1.29 | -0.10 | -7.19% | 1.39 | 1.39 | 1.27 |
Apr 11, 2024 | 1.38 | 0.03 | 2.22% | 1.35 | 1.42 | 1.31 |
Apr 10, 2024 | 1.33 | 0.02 | 1.53% | 1.31 | 1.38 | 1.30 |
Apr 9, 2024 | 1.37 | -0.02 | -1.44% | 1.39 | 1.43 | 1.31 |
Apr 8, 2024 | 1.43 | 0.04 | 2.88% | 1.39 | 1.44 | 1.36 |
Apr 5, 2024 | 1.37 | -0.05 | -3.52% | 1.42 | 1.44 | 1.36 |
Apr 4, 2024 | 1.41 | 0.08 | 6.02% | 1.33 | 1.53 | 1.33 |
Apr 3, 2024 | 1.35 | -0.02 | -1.46% | 1.37 | 1.39 | 1.29 |
Apr 2, 2024 | 1.37 | 0.00 | 0.00% | 1.37 | 1.41 | 1.34 |
Apr 1, 2024 | 1.43 | -0.04 | -2.72% | 1.47 | 1.49 | 1.34 |
Mar 28, 2024 | 1.45 | 0.11 | 8.21% | 1.34 | 1.57 | 1.31 |
Mar 27, 2024 | 1.37 | 0.11 | 8.73% | 1.26 | 1.43 | 1.26 |
Mar 26, 2024 | 1.28 | 0.03 | 2.40% | 1.25 | 1.32 | 1.24 |
Mar 25, 2024 | 1.25 | 0.04 | 3.31% | 1.21 | 1.27 | 1.21 |
Mar 22, 2024 | 1.24 | -0.05 | -3.88% | 1.29 | 1.35 | 1.24 |
Mar 21, 2024 | 1.33 | 0.13 | 10.83% | 1.20 | 1.36 | 1.20 |
Lineage Cell Therapeutics, Inc. Events
時間 (UTC) | 國家 | 事件 |
---|---|---|
Thursday, May 9, 2024 | ||
時間 (UTC) 10:59 | 國家 US
| 事件 Q1 2024 Lineage Cell Therapeutics Inc Earnings Release Q1 2024 Lineage Cell Therapeutics Inc Earnings ReleaseForecast(預報) -返回 - |
Tuesday, June 11, 2024 | ||
時間 (UTC) 10:59 | 國家 US
| 事件 Lineage Cell Therapeutics Inc Annual Shareholders Meeting Lineage Cell Therapeutics Inc Annual Shareholders MeetingForecast(預報) -返回 - |
Thursday, August 8, 2024 | ||
時間 (UTC) 10:59 | 國家 US
| 事件 Q2 2024 Lineage Cell Therapeutics Inc Earnings Release Q2 2024 Lineage Cell Therapeutics Inc Earnings ReleaseForecast(預報) -返回 - |
- 每年
- 每季度
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
總收入 | 14.703 | 4.341 | 1.826 | 3.515 | 4.988 |
收入 | 14.703 | 4.341 | 1.826 | 3.515 | 4.988 |
收入成本,共計 | 0.728 | 1.426 | 0.385 | 0.412 | 0.302 |
毛利 | 13.975 | 2.915 | 1.441 | 3.103 | 4.686 |
總營業費用 | 37.223 | 53.029 | 28.273 | 42.391 | -31.728 |
銷售/一般/行政費用,總計 | 22.508 | 18.212 | 15.571 | 24.031 | 24.726 |
研究與開發 | 13.887 | 33.714 | 11.117 | 15.948 | 18.755 |
異常費用(收入) | 0 | -0.523 | 0 | -77.711 | |
營業收入 | -22.52 | -48.688 | -26.447 | -38.876 | 36.716 |
利息收入(費用),非經營淨值 | -1.365 | 3.727 | 1.817 | 16.499 | -82.531 |
其他,淨值 | -1.927 | 1.691 | 2.706 | 3.143 | -1.315 |
稅前淨收入 | -25.812 | -43.27 | -21.924 | -19.234 | -47.13 |
稅後淨收入 | -26.353 | -43.27 | -20.685 | -11.827 | -46.784 |
少數股東權益 | 0.08 | 0.251 | 0.036 | 0.118 | 0.794 |
未計算非常項目前的淨收益 | -26.273 | -43.019 | -20.649 | -11.709 | -45.99 |
淨收入 | -26.273 | -43.019 | -20.649 | -11.709 | -45.99 |
Total Adjustments to Net Income | |||||
普通股股東可獲收益 (不含非經常性項目) | -26.273 | -43.019 | -20.649 | -11.709 | -45.99 |
普通股股東可獲收益 (含非經常性項目) | -26.273 | -43.019 | -20.649 | -11.709 | -45.99 |
攤薄調整 | |||||
攤薄淨收入 | -26.273 | -43.019 | -20.649 | -11.709 | -45.99 |
攤薄後加權平均股 | 169.792 | 164.502 | 150.044 | 145.533 | 126.903 |
扣除特別項目的每股攤薄盈利 | -0.15474 | -0.26151 | -0.13762 | -0.08046 | -0.3624 |
每股正常攤薄盈利 | -0.15474 | -0.26469 | -0.13762 | -0.08046 | -0.75823 |
Depreciation / Amortization | 0.1 | 0.2 | 1.2 | 2 | 2.2 |
Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | |
---|---|---|---|---|---|
總收入 | 3.225 | 2.386 | 1.915 | 2.998 | 4.553 |
收入 | 3.225 | 2.386 | 1.915 | 2.998 | 4.553 |
收入成本,共計 | 0.127 | 0.119 | 0.102 | 0.235 | 0.215 |
毛利 | 3.098 | 2.267 | 1.813 | 2.763 | 4.338 |
總營業費用 | 8.249 | 9.028 | 8.554 | 8.249 | 8.787 |
銷售/一般/行政費用,總計 | 4.249 | 4.724 | 4.348 | 4.422 | 5.27 |
研究與開發 | 3.873 | 4.185 | 4.104 | 3.592 | 3.302 |
Depreciation / Amortization | |||||
營業收入 | -5.024 | -6.642 | -6.639 | -5.251 | -4.234 |
利息收入(費用),非經營淨值 | 0.232 | 0.45 | -0.123 | 0.151 | -0.658 |
其他,淨值 | -0.411 | -0.015 | 0.4 | -0.475 | -1.89 |
稅前淨收入 | -5.203 | -6.207 | -6.362 | -5.575 | -6.782 |
稅後淨收入 | -5.203 | -4.404 | -6.362 | -6.116 | -6.782 |
少數股東權益 | -0.026 | 0.032 | 0.008 | 0.047 | 0.019 |
未計算非常項目前的淨收益 | -5.229 | -4.372 | -6.354 | -6.069 | -6.763 |
淨收入 | -5.229 | -4.372 | -6.354 | -6.069 | -6.763 |
普通股股東可獲收益 (不含非經常性項目) | -5.229 | -4.372 | -6.354 | -6.069 | -6.763 |
普通股股東可獲收益 (含非經常性項目) | -5.229 | -4.372 | -6.354 | -6.069 | -6.763 |
攤薄淨收入 | -5.229 | -4.372 | -6.354 | -6.069 | -6.763 |
攤薄後加權平均股 | 170.592 | 170.127 | 170.002 | 169.786 | 169.731 |
扣除特別項目的每股攤薄盈利 | -0.03065 | -0.0257 | -0.03738 | -0.03574 | -0.03985 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
每股正常攤薄盈利 | -0.03065 | -0.0257 | -0.03738 | -0.03574 | -0.03985 |
異常費用(收入) | 0 | 0 | 0 |
- 每年
- 每季度
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
流動資産總額 | 60 | 111.549 | 43.999 | 57.519 | 36.358 |
現金和短期投資 | 57.875 | 58.358 | 41.562 | 30.716 | 30.741 |
現金等價物 | 11.355 | 55.742 | 32.585 | 9.497 | 23.587 |
短期投資 | 46.52 | 2.616 | 8.977 | 21.219 | 7.154 |
應收賬款總額,淨額 | 0.297 | 50.84 | 0.004 | 23.94 | 3.719 |
應收賬款 - 貿易,淨額 | 0.297 | 50.84 | 0.004 | 0.044 | 0.891 |
預付的費用 | 1.828 | 2.351 | 2.433 | 2.863 | 1.898 |
總資産 | 123.664 | 174.545 | 107.949 | 125.478 | 101.66 |
物業/廠房/設備,總計 - 淨額 | 5.673 | 4.872 | 5.63 | 8.175 | 5.835 |
物業/廠房/設備,總計 - 總額 | 11.523 | 10.174 | 9.945 | 12.766 | 9.02 |
累計折舊,總計 | -5.85 | -5.302 | -4.315 | -4.591 | -3.185 |
無形資産,淨額 | 46.692 | 46.822 | 47.032 | 48.248 | 3.125 |
長期投資 | 0 | 33.733 | |||
其他長期資産,總計 | 0.627 | 0.63 | 0.616 | 0.864 | 0.505 |
流動負債總額 | 18.981 | 47.116 | 7.769 | 6.494 | 6.812 |
應付賬款 | 2.393 | 3.543 | 2.611 | 2.427 | 2.359 |
預提費用 | 7.131 | 25.049 | 4.416 | 3.985 | 4.332 |
應付票據/短期債務 | 0 | 0 | 0.523 | 0 | 0 |
長期債務的當前部分/資本租賃 | 0.036 | 0.03 | 0.016 | 0.033 | 0.07 |
其他流動負債,總計 | 9.421 | 18.494 | 0.203 | 0.049 | 0.051 |
負債總額 | 50.325 | 82.324 | 11.75 | 12.519 | 7.82 |
長期債務總額 | 0.084 | 0.03 | 0.026 | 0.077 | 1.958 |
長期債務 | 0 | ||||
資本租賃義務 | 0.084 | 0.03 | 0.026 | 0.077 | 1.958 |
少數股權 | -1.403 | -1.323 | -1.072 | -1.712 | -1.594 |
其他負債,總計 | 30.587 | 34.425 | 2.951 | 4.345 | 0.644 |
股權 | 73.339 | 92.221 | 96.199 | 112.959 | 93.84 |
Preferred Stock - Non Redeemable, Net | 0 | 0 | 0 | ||
普通股 | 440.28 | 434.529 | 393.944 | 387.062 | 354.27 |
留存收益(累計赤字) | -363.37 | -337.097 | -294.078 | -273.422 | -261.856 |
Treasury Stock - Common | |||||
其他權益,總計 | -3.571 | -5.211 | -3.667 | -0.681 | 1.426 |
總負債和股東權益 | 123.664 | 174.545 | 107.949 | 125.478 | 101.66 |
已發行普通股總數 | 170.093 | 169.477 | 153.096 | 149.804 | 127.136 |
應收票據 - 長期 | 0 | 22.104 | |||
商譽,淨額 | 10.672 | 10.672 | 10.672 | 10.672 | |
遞延所得稅 | 2.076 | 2.076 | 2.076 | 3.315 |
Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | |
---|---|---|---|---|---|
流動資産總額 | 43.481 | 48.491 | 49.655 | 60 | 68.509 |
現金和短期投資 | 41.332 | 45.925 | 46.814 | 57.875 | 66.355 |
現金等價物 | 31.474 | 33.886 | 15.451 | 11.355 | 24.752 |
短期投資 | 9.858 | 12.039 | 31.363 | 46.52 | 41.603 |
應收賬款總額,淨額 | 0.432 | 0.443 | 0.203 | 0.297 | 0.434 |
應收賬款 - 貿易,淨額 | 0.432 | 0.443 | 0.203 | 0.297 | 0.434 |
預付的費用 | 1.717 | 2.123 | 2.638 | 1.828 | 1.72 |
總資産 | 106.153 | 111.688 | 113.205 | 123.664 | 131.148 |
物業/廠房/設備,總計 - 淨額 | 4.854 | 5.31 | 5.584 | 5.673 | 4.652 |
物業/廠房/設備,總計 - 總額 | 11.448 | 11.693 | 11.694 | 11.523 | 10.464 |
累計折舊,總計 | -6.594 | -6.383 | -6.11 | -5.85 | -5.812 |
商譽,淨額 | 10.672 | 10.672 | 10.672 | 10.672 | 10.672 |
無形資産,淨額 | 46.594 | 46.627 | 46.659 | 46.692 | 46.724 |
其他長期資産,總計 | 0.552 | 0.588 | 0.635 | 0.627 | 0.591 |
流動負債總額 | 15.881 | 16.052 | 17.225 | 18.981 | 22.739 |
應付賬款 | 2.43 | 2.187 | 3.001 | 2.393 | 2.865 |
預提費用 | 3.481 | 3.431 | 3.126 | 7.131 | 7.46 |
應付票據/短期債務 | 0 | 0 | 0 | 0 | 0 |
長期債務的當前部分/資本租賃 | 0.055 | 0.054 | 0.051 | 0.036 | 0.025 |
其他流動負債,總計 | 9.915 | 10.38 | 11.047 | 9.421 | 12.389 |
負債總額 | 38.036 | 39.021 | 42.755 | 50.325 | 52.2 |
長期債務總額 | 0.097 | 0.113 | 0.133 | 0.084 | 0.016 |
資本租賃義務 | 0.097 | 0.113 | 0.133 | 0.084 | 0.016 |
遞延所得稅 | 0.273 | 0.273 | 0.273 | 2.076 | 2.076 |
少數股權 | -1.457 | -1.409 | -1.435 | -1.403 | -1.395 |
其他負債,總計 | 23.242 | 23.992 | 26.559 | 30.587 | 28.764 |
股權 | 68.117 | 72.667 | 70.45 | 73.339 | 78.948 |
普通股 | 450.282 | 448.249 | 441.299 | 440.28 | 439.148 |
留存收益(累計赤字) | -380.081 | -372.971 | -367.742 | -363.37 | -357.016 |
其他權益,總計 | -2.084 | -2.611 | -3.107 | -3.571 | -3.184 |
總負債和股東權益 | 106.153 | 111.688 | 113.205 | 123.664 | 131.148 |
已發行普通股總數 | 174.987 | 174.439 | 170.174 | 170.093 | 169.886 |
Preferred Stock - Non Redeemable, Net | 0 | 0 | 0 | 0 | 0 |
- 每年
- 每季度
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
淨收入/起跑線 | -26.273 | -43.019 | -20.649 | -11.709 | -45.99 |
經營活動産生的現金 | 1.059 | -23.561 | -19.753 | -31.947 | -30.882 |
經營活動産生的現金 | 0.582 | 0.663 | 0.895 | 1.131 | 1.081 |
Amortization | 0.145 | 0.21 | 1.216 | 1.998 | 2.192 |
Deferred Taxes | |||||
非現金物品 | 7.901 | -2.511 | -2.516 | -21.464 | 11.197 |
已付現金利息 | 0.013 | 0.013 | 0.02 | 0.028 | 0.155 |
營運資金的變化 | 18.704 | 21.096 | 1.301 | -1.903 | 0.638 |
投資活動産生的現金 | -46.159 | 9.745 | 13.038 | 16.957 | 11.816 |
資本支出 | -0.413 | -0.354 | -0.064 | -0.44 | -3.287 |
其他投資現金流量項目,總計 | -45.746 | 10.099 | 13.102 | 17.397 | 15.103 |
融資活動産生的現金 | 1.632 | 36.93 | 29.865 | 0.617 | 5.774 |
融資現金流項目 | -0.123 | -1.155 | -0.383 | 0.654 | 0.161 |
股票的發行(報廢),淨額 | 1.787 | 38.105 | 5.127 | 0.063 | 5.962 |
債務的發行(退還),淨額 | -0.032 | -0.02 | 25.121 | -0.1 | -0.349 |
外彙效應 | -0.873 | -0.02 | -0.063 | 0.07 | 0.006 |
現金淨變化 | -44.341 | 23.094 | 23.087 | -14.303 | -13.286 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
Net income/Starting Line | -4.372 | -26.273 | -19.919 | -13.85 | -7.087 |
Cash From Operating Activities | -11.242 | 1.059 | 9.362 | 14.842 | 21.904 |
Cash From Operating Activities | 0.138 | 0.582 | 0.441 | 0.296 | 0.15 |
Amortization | 0.033 | 0.145 | 0.113 | 0.065 | 0.032 |
Non-Cash Items | 1.098 | 7.901 | 7.168 | 5.861 | 1.685 |
Cash Interest Paid | 0.002 | 0.013 | 0.013 | 0.009 | 0.005 |
Changes in Working Capital | -8.139 | 18.704 | 21.559 | 22.47 | 27.124 |
Cash From Investing Activities | 15.426 | -46.159 | -41.057 | -0.143 | -0.046 |
Capital Expenditures | -0.188 | -0.413 | -0.429 | -0.143 | -0.046 |
Other Investing Cash Flow Items, Total | 15.614 | -45.746 | -40.628 | 0 | 0 |
Cash From Financing Activities | 0.001 | 1.632 | 1.51 | 0.546 | 0.513 |
Financing Cash Flow Items | -0.037 | -0.123 | -0.112 | -0.074 | -0.008 |
Issuance (Retirement) of Stock, Net | 0.051 | 1.787 | 1.645 | 0.635 | 0.529 |
Foreign Exchange Effects | -0.1 | -0.873 | -0.795 | -0.161 | -0.042 |
Net Change in Cash | 4.085 | -44.341 | -30.98 | 15.084 | 22.329 |
Deferred Taxes | 0 | 0 | |||
Issuance (Retirement) of Debt, Net | -0.013 | -0.032 | -0.023 | -0.015 | -0.008 |
Cash Taxes Paid | 1.803 |
差價合約交易計算器
計算您的假設損益
交易佣金
0
- 1:1
槓桿
1:1
- 20
- 100
- 500
- 1000
- 10000
交易
交易規模(槓桿 x 投資):
打開
拋售
已賣出 做多
Industry: | Biotechnology & Medical Research (NEC) |
2173 Salk Ave Ste 200
CARLSBAD
CALIFORNIA 92008-7354
US
盈虧控制
- Annual
- Quarterly
人們也觀看
還在尋找值得信賴的經紀商?
加入全球 610,000 多名交易者,選擇與 Capital.com 交易